氧氟沙星在胶束体系中的荧光特性及应用

研究发现十二烷基硫酸钠胶束对氧氟沙星荧光有明显的增敏作用，据此建立了直接测定人体尿液中氧氟沙星的等波长差同步荧光光谱法（△λ=90nm）。经样品测定，其线性范围为0．12－3．6mg/L，检出限为0．12mg/L，回收率为92．2％－97．8％，相对标准偏差为1．2％－2．7％。     

环丙沙星荷移反应及荧光光谱性质研究

研究了环丙沙星（CPFX）与电子受体2，3－二氰－5，6－二氯－1，4对苯酯（DDQ）之间的荷移反应。实验结果表明：DDQ与CPFX的荷移反应需在丙酮－甲醇（1：4）介质中进行。两者于40℃水浴中恒温30min即可形成1：1络合物，其荧光发射较CPFX有显著的增强。在0．107．2mg/L浓度范围内，荧光强度与质量浓度呈良好线性关系；其检出限为0．1mg/L。本方法用于片剂中环丙沙星的含量测定，其回收率为96．6％－100．2％；标准偏差为1．3％－2．6％。     

司帕沙星金属络合物在胶束体系中的荧光特性研究及应用

研究了在金属离子存在下司帕沙星在胶束体系中的荧光特性,首次发现锌（Ⅱ）和阴离子表面活性剂十二烷基硫酸钠对司帕沙星的荧光有显著的协同增敏作用,据引建立了测定人体尿液中司帕沙星含量的同步－导数荧光光谱法,定量线性范围为０．０４～４．０ｍｇ／Ｌ,检测限为０．０４ｍｇ／Ｌ。相对标准偏差为１．６％～３．９％。探讨了锌（Ⅱ）和十二烷基硫酸钠对司帕沙星荧光的增敏机理。     

纸色谱分离-荧光检测法测定人体尿液中的黄蝶呤

报道用丙醇-氨水(25％)-水(15：9：6．V／V)作展开剂,纸色谱分离人体尿液中的蝶呤类化合物,并利用黄蝶呤与其它蝶呤类化合物的荧光性质的差异来测定人体尿液中黄蝶呤的含量。黄蝶呤在0～0．6μg／10mL的范围内,其荧光强度与其荧光斑点的洗脱量呈良好的线性关系,从而建立了一种新的测定黄蝶呤的方法。该方法应用于人体尿液中黄蝶呤的测定,结果满意。     

硫酸颜色反应用于荧光法测定利血平研究

提出了硫酸颜色反应用于利血平的荧光分析新方法。利用血平与浓硫酸反应，生成强荧光物质，所得产物的荧光强度与利血平的浓度在０－０．６μｇ／ｍＬ范围内有良好的线性关系。检测限为０．２ｎｇ／ｍＬ。本法可直接用于尿液中利血平的定量分析，回收率为８２．５％－８４．２％。     

铕-芦氟沙星的氧化产物- EDTA 配合体系的敏化荧光

提出了测定人体尿液中芦氟沙星的 Eu3＋敏化荧光法,研究了芦氟沙星在 HAc介质中被 H2O2氧化的反应机理。在近中性 HAc－ NaAc缓冲溶液中芦氟沙星的氧化产物与 Eu3＋、 EDTA形成三元络合物,产生 Eu3＋的特征荧光（λ em 617 nm、λ ex 352 nm）,其荧光强度与芦氟沙星的浓度成线性关系。尿液标准曲线线性范围 5.0× 10－ 8～ 2.5× 10－ 6 mol/L,检出限 1.5× 10－ 8 mol/L。方法简单、快速、灵敏。     

6-甲氧基-2-丙酰基萘在醇溶剂中的溴化反应

室温下，6－甲氧基－2－丙酰基萘和1，3－二溴－5，5－二甲基海因的溴化反应在醇溶剂中，反应速度快、转化率高，生成5－溴－6－甲氧基－2－丙酰基萘的收率高（98．59％）。     

高效液相色谱-荧光光度检测尿液中溴鼠灵

提出了高效液相色等荧光光度检测尿液中溴鼠录。尿液经磷酸酸化至pH2．0并在LC-18固相萃取小柱上富集、净化,分取10．0μL试样溶液进行高效液相色谱测定。用XDB C18柱（150mm×2．1mm,5μm）为固定相,以甲醇及稀乙酸溶液（2＋998）以88比12的比例混合后作为流动相,在激发波长为270nm,发射波长为376nm的条件下进行荧光光度检测。结果表明：溴鼠灵在0．05～10．0mg·L^-1范围内呈线性关系,方法的回收率在79．8％～97．0％之间,相对标准偏差在4．0％～4．9％之间,测定限为0．07mg·L^-1。     

纸基质室温Lin光法研究氧氟沙星体内药代动力学

本文建立了滤纸基质室温Lin光（PS－RTP）法测定人尿中氧氟沙星含量的新方法,并将该法用于人尿中氧氟沙星回收率和排出速率的测定,实验表明：氧氟沙星在尿液中的平均回收率为99．1％,相对标准偏差RSD＜1．7％。给药后24h内的排泄率为77．7％,氧氟沙星最大药物浓度出现的时间为2．5－4h。     

色氨酸荧光猝灭法测定人发稀土总量

研究了稀土元素对色氨酸的荧光猝灭效应，结果发现，在pH=11的HAc-H3BO3-H3PO4-NaOH缓冲溶液中，。各种稀土元素对色氨酸的荧光有猝灭效应，在此基础上建立了色氨酸荧光猝灭法测定稀土总量的分析新方法。稀土总量在0－50ug/25mL范围内，色氨酸荧光强度的差值与稀土总量呈现良好的线性关系，方法检出限为0．23ug/L；相对标准偏差为1．1％－2．9％；样品加标回收率为98．9％－101．2％，方法简便，灵敏度高，已用于人发样品中稀土总量测定。     

测定尿中痕量碘的高锰酸钾-亚砷酸体系催化光度法

在硫酸和磷酸的介质中,碘离子催化高猛酸钾与亚砷酸反应生成的锰（Ⅲ）氧化砷酸的反应,据此建立了催化光度法测定痕量碘的新方法。该法的检出限为0．4μg/L,测定的线性范围为1．0－25．0μg/L。应用该法测定了尿样中痕量碘的含量,获得了满意的结果,测定样品的相对标准偏差（n＝6）为2．5％－3．7％,加标回收率为96．4％－102．6％。     

UPLC–MS/MS method validation of ciprofloxacin in human urine: Application to biodegradability study in microbial fuel cell

To enable the reliable quantification of ciprofloxacin in human urine, a sensitive and selective assay based on liquid chromatography–tandem mass spectrometry was developed. The chromatographic separation of the ciprofloxacin was carried out on a Zorbex Eclipse C₁₈ column using methanol and ammonium acetate as a mobile phase by the gradient elution method. The developed assay covered a wide range of concentrations (1.56–100 ng/mL) with a lower limit of detection of 0.76 ng/mL. Quantification was performed using the multiple reaction monitoring transitions 331.8/231 for ciprofloxacin and 362/318 for ofloxacin (internal standard). This assay was validated for linearity, accuracy, precision and recovery. The validated method was then applied to the biodegradability of ciprofloxacin (99%) from human urine in the microbial fuel cell.     

碳糊电极阳极吸附伏安法测定环丙沙星

报道了用碳糊电极阳极吸附伏安法测定环丙沙星的新方法.在 0. 40mol/L的NH4Ac HAc(pH4. 30)缓冲液中,使用JP 303极谱分析仪,环丙沙星在碳糊电极 (CPE)上有一灵敏的吸附伏安氧化峰,峰电位为1. 12V(vs.SCE).该氧化峰的二阶导数峰电流与环丙沙星的浓度在 8. 0×10-9 ~8. 0×10-7 mol/L(富集 90s)范围内成良好的线性关系,相关系数为 0. 998 8,检出限为 4. 0×10-9 mol/L(S/N=3,富集 110s).探讨了环丙沙星在碳糊电极上的伏安性质和电极反应机理,并且成功应用于人体尿样中环丙沙星含量的测定.加入回收实验,回收率在95. 5%至 103. 9%之间.     

西班牙Quinton海洋水生命元素测定及功能评价

目的应用电感耦合等离体子质谱(ICP-MS)检测法测定西班牙Quinton海洋水中的生命元素(该文特指人体所需的宏量元素和微量元素)。方法建立电感耦合等离子体质谱(ICPMS)法同时测定Quinton海洋水中21种生命元素含量的分析方法。结果方法检出限为0.01~0.10μg/mL,元素加标回收率为94.12%~104.35%,相对标准偏差为0.3%~12.2%。结论方法简单、快速、准确,适用于海洋水中多元素含量同时测定。并用元素含量评价Quinton海洋水的特性和功能。     

Computational simulation and preparation of fluorescent magnetic molecularly imprinted silica nanospheres for ciprofloxacin or norfloxacin sensing

A magnetic molecularly imprinted fluorescent sensor for the sensitive and convenient determination of ciprofloxacin or norfloxacin in human urine was synthesized and characterized by scanning electron microscopy, Fourier transform infrared spectroscopy, X‐ray diffraction, ultraviolet/visible spectroscopy, and fluorescence spectroscopy. Both cadmium telluride quantum dots and ferroferric oxide nanoparticles are introduced into the polymer for the rapid separation and detection of the target molecules. The synthesized molecularly imprinted polymers were applied to detect ciprofloxacin or its structural analog norfloxacin in human urine with the detection limit 130 ng/mL. A computational study was developed to evaluate the template–monomer geometry and interaction energy in the polymerization mixture to determine the reaction molar ratio of the template and monomer molecules.     

Simultaneous determination of levofloxacin and ciprofloxacin in human urine by ionic‐liquid‐based,dual‐template molecularly imprinted coated graphene oxide monolithic solid‐phase extraction

A novel method was developed to simultaneously determine the ciprofloxacin and levofloxacin levels in human urine using an ionic‐liquid‐based, dual‐molecularly imprinted polymer‐coated graphene oxide solid‐phase extraction monolithic column coupled with high‐performance liquid chromatography. The molecularly imprinted monolithic column was prepared using ciprofloxacin and levofloxacin as templates, 1‐vinyl‐3‐ethylimidazolium bromide as the functional monomer, and graphene oxide as the core material. The resulting imprinted monoliths were characterized by scanning electron microscopy and fourier transform‐infrared spectroscopy. The efficiency and capacity of the ionic‐liquid‐based imprinted monolithic column were investigated by varying the synthesis conditions (ciprofloxacin/levofloxacin ratio and template/functional monomer/cross‐linker ratio). The solid‐phase extraction process was optimized by changing the washing and eluting conditions. The results suggested that the proposed ionic‐liquid‐based molecularly imprinted solid‐phase extraction monolithic‐high‐performance liquid chromatography method could separate ciprofloxacin and levofloxacin efficiently and simultaneously from human urine. The mean recoveries of ciprofloxacin and levofloxacin ranged from 89.2 to 93.8 and 86.7 to 94.6%, respectively. The intra‐ and interday relative standard deviation ranged from 0.9 to 3.2 and 0.8 to 2.9%, respectively. Under the optimized conditions, the recoveries of ciprofloxacin and levofloxacin were more than 93.8%.     

Determination of Ciprofloxacin,Enrofloxacin, and Marbofloxacin in Bovine Urine,Serum, and Milk by Microextraction by a Packed Sorbent Coupled to Ultra-High Performance Liquid Chromatography

This article reports new, easy, and rapid microextraction by packed sorbent (MEPS)–ultra high performance liquid chromatography with photodiode array detection for the simultaneous determination in bovine urine, serum, and milk of three antibiotics belonging to the class of the fluoroquinolones, namely ciprofloxacin, enrofloxacin, and marbofloxacin, approved for veterinary and human use (ciprofloxacin). The chromatographic separation of the analytes and all aspects influencing the MEPS performance were optimized for the extraction from the considered biological samples. The optimized procedure required simple sample pretreatment, a short (<8?min) isocratic elution, and provided sufficient sensitivity for the determination of the analytes at trace levels in compliance with current legislation. Limits of quantitation were in the range from 0.002 (ciprofloxacin, urine) to 0.048?μg/mL (enrofloxacin, milk). Recoveries from 79% (enrofloxacin, milk) to 88% (ciprofloxacin, urine/serum) were obtained on spiked samples. The within-day (n?=?6) and between-day (n?=?6 over 3?days) relative standard deviation percentages in bovine urine, serum, and milk samples ranged from 2.2 (ciprofloxacin, urine) to 2.5 (enrofloxacin, serum) and from 3.1 (ciprofloxacin, urine) to 3.7 (enrofloxacin, milk), respectively, and were not concentration dependent. To the best of our knowledge, this is the first study describing a fast and simple method for the determination of fluoroquinolones in bovine biological samples.     

Heavily Boron Doped Diamond Electrodes for Ultra Sensitive Determination of Ciprofloxacin in Human Urine

Ciprofloxacin is one of the most potent fluoroquinolone antibiotics in medical treatment with a widely effective antibacterial activity. Aim of the presented paper was to use boron doped diamond electrodes for a sensitive, simple and reliable voltammetric determination of ciprofloxacin in human urine samples. Prior to the electrochemical analyses, an optimal boron doping level was determined in order to achieve the highest sensitivity. A set of boron doped diamond electrodes with the doping level in the range from 0 to 20 000 ppm B/C was used for this purpose. Electrochemical behavior of ciprofloxacin was investigated using cyclic voltammetry in an ammonium acetate buffer (pH 5), where ciprofloxacin provided a well‐defined irreversible oxidation peak at a potential of + 1.15 V. Under optimal experimental conditions, the calibration curve obtained by square‐wave voltammetry was linear in a concentration range from 0.15 to 2.11 μmol/L (R²=0.9974). A very low limit of detection (0.05 μmol/L) was obtained for the BDD electrode with the highest doping level. The developed square wave method was successfully applied to the determination of ciprofloxacin in human urine samples with a very good recovery (from 97 to 102%).     

液相色谱-串联质谱法测定尿液中的泛酸

该文建立了检测尿液中泛酸含量的液相色谱-串联质谱(HPLC-MS/MS)方法,尿液经过离心、稀释后,采用ACPUITY UPLC SS T3(2.1 mm×100 mm,1.8μm)色谱柱进行分离,电喷雾正离子模式电离,多反应监测模式进行检测,方法的线性关系良好(r=0.999 3),方法检出限为0.46 ng/m L,回收率为87.9%~95.3%,相对标准偏差(RSD)为2.5%~13.0%。该方法具有灵敏度高、分析时间短等特点,可用于尿液中泛酸含量的分析。     

Novel molecularly imprinted monolithic column for selective on-line extraction of ciprofloxacin from human urine

Water-compatible ciprofloxacin-imprinted monolithic columns were synthesized in water-containing systems for selective extraction of ciprofloxacin from human urine samples. Methanol-water (10:3, v/v) was used as a porogenic solvent and the obtained monolithic imprinted polymers reveal high selectivity to ciprofloxacin in an aqueous environment; the affinity can be easily controlled by adjusting the pH of the mobile phase. Owing to the unique porous structure and flow-through channels existing in the network skeleton of the monolithic MIP, urine samples could be directly injected into the column, proteins and other biological matrix were quickly washed out and ciprofloxacin was selectively retained and enriched. Good linearity was obtained from 0.08 to 400 mg/L (r=0.998) with the relative standard deviations less than 3.6%. The limit of detection of the method was 0.04 mg/L and the recoveries were more than 94.5% at three different concentrations. Moreover, by increasing the injection volume to 2.0 mL, the sensitivity of the method could be improved 100-fold according to the peak height of ciprofloxacin. This expedient greatly simplified the overall procedure, resulting in a rapid and efficient sample analysis while maintaining precision and accuracy.